Paid Clinical Trials in Jupiter, FL
As of August 2026, 41 paid clinical trials are recruiting in Jupiter, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Jupiter offers studies at sites including Jupiter Medical Center for conditions such as Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Epithelial Ovarian Cancer, Gout. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Jupiter
Trials by drug in Jupiter
Filter results
41 clinical trials
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Patient Retrospective Outcomes (PRO)
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Prospective Study to Assess a Diagnostic Aid for Cancer
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RA-PRO PRAGMATIC TRIAL
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
Pilot Trial of the RUBI Program for Autistic Adults
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Top Research Study Locations in Jupiter
Researchers run research studies in Jupiter, FL at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Jupiter Medical Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 15 |
| Kailera Clinical Site | Obesity, Overweight, Obesity With Diabetes | 3 |
| Health Awareness, Inc. | Gout, Metabolic Dysfunction-associated Steatohepatitis, Metabolic Dysfunction-Associated SteatoHepatitis (MASH) | 3 |
| Health Awareness Inc | Gout, Tophaceous Gout | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Advanced Pain Management and Wellness Center | Lumbar Spinal Stenosis | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| Azzi ENT and Facial Reconstructive Surgery | Cancer | 1 |
| Els for Autism Foundation | Autism Spectrum Disorder, Behavior, Parenting | 1 |
| Galderma Investigational | Atopic Dermatitis | 1 |
| Health Awareness | Metabolic Dysfunction-Associated Steatotic Liver Disease | 1 |
| Health Awareness, Inc. - Jupiter | Diabetic Peripheral Neuropathic Pain | 1 |
| Jupiter Med Ctr | Lumbar Spinal Stenosis | 1 |
| Jupiter Medical Cancer | Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement) | 1 |
| Jupiter Medical Center/Anderson Family Cancer Institute | Multiple Myeloma | 1 |
| Jupiter Outpatient Surgery Center | Lumbar Spinal Stenosis | 1 |
| Jupiter Research | Leukemia, Myeloid, Acute | 1 |
| Louis J. Raso, MD, PA | Chronic Pain | 1 |
| Palm Beach Rheumatology and Wellness | Rheumatoid Arthritis | 1 |
| The Raso Pain Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Jupiter (2026)
Recruiting trials in Jupiter grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · Natera, Inc.
Diabetes & metabolic (4 active studies)
Neurology & pain (2 active studies)
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
- Patient Retrospective Outcomes (PRO) · Boston Scientific Corporation
Common conditions studied in Jupiter
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Epithelial Ovarian Cancer (2 active studies)
- Gout (2 active studies)
- Lumbar Spinal Stenosis (2 active studies)
- Obesity (2 active studies)
Leading research sponsors in Jupiter
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- Crystalys Therapeutics
- Kailera
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Jupiter?
There are approximately 41 recruiting clinical trials in Jupiter, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Jupiter pay participants?
Most recruiting trials in Jupiter compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Jupiter?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Jupiter?
The most common conditions under active study in Jupiter include Anatomic Stage I Breast Cancer AJCC v8 (2), Anatomic Stage II Breast Cancer AJCC v8 (2), Epithelial Ovarian Cancer (2), Gout (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Jupiter?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Jupiter on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Jupiter?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Jupiter?
Recruiting research sites in Jupiter include Jupiter Medical Center, Kailera Clinical Site, Health Awareness, Inc., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Jupiter right now?
The largest active categories in Jupiter are Cancer & tumors (21), Diabetes & metabolic (4), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.